Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.50

€7.50

1.350%
0.1
1.350%
€6.53
 
28.03.24 / Tradegate WKN: A1XB32 / Symbol: INGN / Name: Inogen / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Inogen Inc. Stock

There is an upward development for Inogen Inc. compared to yesterday, with an increase of €0.10 (1.350%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Inogen Inc. stock is not clear.
With a target price of 6 € there is a slightly negative potential of -20.0% for Inogen Inc. compared to the current price of 7.5 €.

Pros and Cons of Inogen Inc. in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Inogen Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Inogen Inc. 1.350% 14.504% 29.310% -35.345% 41.509% -82.394% -
Orasure Tech 0.890% -5.085% -16.418% 4.673% -24.832% -36.000% -42.327%
scPharmaceuticals 1.770% -11.373% -17.064% -42.420% -21.391% -19.286% -
SI-BONE Inc 8.510% -3.425% -12.422% 20.513% -25.789% -43.600% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-10-30

Upon examining the financial data supplied for Inogen Inc. — a prominent player in the Healthcare Equipment and Supplies industry — it's clear to see that the company has recently navigated a challenging financial landscape. Notably, over the past three operational years, a trend of fluctuating balance sheets, income statements, and cash flow data seems to suggest volatility in the company's financial standing.

A deeper look into Inogen's financials reveals some potential strengths. Despite fluctuating numbers, the company demonstrated a notable increase in total assets from 2020 to 2021, highlighting an opportunistic approach to resource acquisition. Additionally, Inogen's total revenue seemingly reflected a steady upward trend from 2020 to 2022, indicating an increase in incoming cash - a crucial factor for any growing firm.

In terms of financial ratios for valuation, the Price to Sales (P/S) ratio (PriceSalesTTM) for the trailing 12 months (TTM) is currently at 1.2258. This suggests that investors are willing to pay over a dollar for each dollar of sales, reflecting perceived value in the company's income-generating abilities. Moreover, the company's enticing Book Value of 11.847 implies significant intrinsic value, which may encourage investor confidence.

Comments

Inogen, Inc. (NASDAQ: INGN) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Ratings data for INGN provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 52.72%
Target price 6.535
Change
Ends at 08.11.24

Inogen, Inc. (NASDAQ: INGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $8.00 to $7.00. They now have an "underweight" rating on the stock.
Ratings data for INGN provided by MarketBeat
Show more

News

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4): https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the